Beta Drugs Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Rahul Batra, was filed 08 Nov 2021.
Beta Drugs Limited: what insiders have been doing
Beta Drugs Limited is a Health Care company. Its directors and officers file their transactions with SEBI (PIT + SAST). From 22 October 2025 to 22 October 2026, the disclosure feed for Beta Drugs Limited logged 1 filing by 1 insider.
All open-market trades in the period are sales: 1 sale worth €3.0M, by 1 insider, with no purchase on record. Biggest ticket of the year: €3.0M, sold by Neeraj Batra and made public on 13 November 2025.
Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning.
Compared with its exchange (1,890 companies, median 4 filings), a count of 1 filing is below the norm. Our records for Beta Drugs Limited go back to 2021, with 1 purchase and 1 sale on the open market in total.
For comparison within the same sector, see the insider buying recorded at Xenon Pharmaceuticals Inc. and Vivos Inc. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Who traded when
BuySaleSince the insiders bought
- +18.5%Entry ₹620.00 · Close at T+365 ₹735.00
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 185,115 shares@ ₹1,685.9989100.0% of flowEquity SharesSEBI:1958a7891f79861bf1281331128fa0c0e8be53dc
- 1,661 sharesEquity SharesSEBI:9611c2def99de32659890625920a08ac384ac287
- 1,982 sharesEquity SharesSEBI:5a1c1a2d761fe314225d6851c3cd5a7a01c1700e
- 29 sharesEquity SharesSEBI:d0226d65f146d2dd2e4d299d89ebebba53ba3eb2
- 317,083 sharesEquity SharesSEBI:e76b9f5253b08792f7304fb0ae298afb2a7d3d33
- 29 sharesEquity SharesSEBI:85f3cf1b417c549f8c1c61ba82b862bb30a66ae7
- 2,400 shares@ ₹685.241749.1% of flowEquity SharesSEBI:a2598f60aaa9edc0f9787e0626d54eecba3e1cbf
- 2,800 shares@ ₹598.121450.9% of flowEquity SharesSEBI:a9788a49c171a20b8ed3b903cb3915519225b9d8Canonical exit: 2 Feb 2022 (T+90)
8 of 8 declarations
About Beta Drugs Limited
Beta Drugs Limited is a company specializing in the healthcare and pharmaceutical sector. It is listed on the XBOM.
